gamma_knife_radiosurgery_for_arteriovenous_malformation

Gamma knife radiosurgery for arteriovenous malformation

Gamma knife radiosurgery for arteriovenous malformation is a safe treatment method although delayed complications may occur. Post-gadolinium enhancement of obliterated nidi may indicate an active post-irradiative process 1).


Enhanced nodular lesion on magnetic resonance imaging and chronic encapsulated expanding haematoma associated with cyst formation may have common aetiopathology caused by late radiation effects, mainly consisting of dilated capillary vessels with wall damage. Massive protein exudation from such damaged capillary vessels is important in cyst development 2).

see Adverse radiation effects

Advances in SRS procedures since 1990s have resulted in a lower risk of radiation induced complications (RICs), but fewer patients had AVM obliteration. Increasing the prescription dose for patients with medium- and large-volume AVMs by using current conformal dose-planning techniques may improve the obliteration rate while maintaining a low risk of RICs 3)

Volume staging remains advantageous over hypofractionation in delivering a higher dose to the target and for better sparing of normal brain tissue in the treatment of large cerebral arteriovenous malformations AVMs. More clinical data are needed, however, to justify the clinical superiority of this increased dose when compared with a hypofractionated treatment regimen 4).

Better conformity can favor the Cyberknife (CK) system for treatment of large AVMs at the cost of higher maximum doses and worse homogeneity. Linac with a micro-multileaf collimator (L-mMLC) is superior when shorter treatment time is required. Neither system can assure satisfying dose gradients outside large targets surrounded by numerous critical structures 5).


1)
Malikova H, Koubska E, Vojtech Z, Weichet J, Syrucek M, Sroubek J, Rulseh A, Liscak R. Late morphological changes after radiosurgery of brain arteriovenous malformations: an MRI study. Acta Neurochir (Wien). 2016 Sep;158(9):1683-90. doi: 10.1007/s00701-016-2876-3. Epub 2016 Jul 1. PubMed PMID: 27368701; PubMed Central PMCID: PMC4980423.
2)
Shuto T, Yagishita S, Matsunaga S. Pathological characteristics of cyst formation following Gamma knife radiosurgery for arteriovenous malformation. Acta Neurochir (Wien). 2014 Dec 13. [Epub ahead of print] PubMed PMID: 25503297.
3)
Pollock BE, Link MJ, Stafford SL, Garces YI, Foote RL. Stereotactic Radiosurgery for Arteriovenous Malformations: The Effect of Treatment Period on Patient Outcomes. Neurosurgery. 2016 Apr;78(4):499-509. doi: 10.1227/NEU.0000000000001085. PubMed PMID: 26990410.
4)
Fogh S, Ma L, Gupta N, Sahgal A, Nakamura JL, Barani I, Sneed PK, McDermott M, Larson DA. High-precision volume-staged Gamma knife radiosurgery and equivalent hypofractionation dose schedules for treating large arteriovenous malformations. J Neurosurg. 2012 Dec;117 Suppl:115-9. doi: 10.3171/2012.7.GKS121023. PubMed PMID: 23205798.
5)
Blamek S, Grządziel A, Miszczyk L. Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations. Radiat Oncol. 2013 Aug 23;8:205. doi: 10.1186/1748-717X-8-205. PubMed PMID: 23968165; PubMed Central PMCID: PMC3766053.
  • gamma_knife_radiosurgery_for_arteriovenous_malformation.txt
  • Last modified: 2024/06/07 03:00
  • by 127.0.0.1